Clin2
NCT07717710Possibly a fitRecruiting

Heart rate medication for healthy adults during exercise

Healthy Adult

Treatments studied

Part of Heart & circulation clinical trials.

This study tests a pill called ivabradine that lowers heart rate, to see how it affects healthy adults when they exercise. Participation requires two supervised exercise sessions.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
19 years to 79 years
Study type
Interventional

Who can take part

  • You must be 19 to 39 years old, or 60 to 79 years old.
  • You must be generally healthy and exercise at least once a week.
  • You must not have heart disease, high blood pressure, asthma, or other chronic illnesses.
  • You must not be a smoker or use cannabis/vaping products.
  • You must not take any regular medications.
  • You must not do more than 150 minutes of moderate-to-vigorous exercise per week.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07797946Not yet recruiting
Ivabradine before sinus surgery for steady heart rate

This trial tests whether giving a drug called ivabradine before sinus surgery helps keep your heart rate steady during the procedure. It may reduce risks during surgery for people with a normal resting heart rate.

NCT07268170Enrolling by invitation· Phase 2/Phase 3
Heart rate control before heart CT scan

This trial tests two medicines to lower heart rate before a cardiac CT scan in adults who need the scan. It is for people whose heart rate is naturally a bit fast (over 65 beats per minute) but not too fast (under 100 bpm).

Herning
NCT07135258Not yet recruiting· Phase 4
Finding the best heart rate target for atrial fibrillation

This study compares different heart rate targets for people with ongoing atrial fibrillation (an irregular heartbeat) to find which one improves symptoms and quality of life. It may help you and your doctor choose the best treatment plan.

Hong Kong
NCT07714746Recruiting· Phase 3
Ivabradine for treating cardiogenic shock after heart attack

This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.

Karachi
NCT06742164Not yet recruiting
Ivabradine for heart rate control in sepsis

This study tests whether a drug called ivabradine can safely lower a fast heart rate in people with sepsis (a severe infection that affects the whole body). It aims to see if controlling heart rate helps improve recovery.

NCT05882708Recruiting· Phase 4
Ivabradine to slow heart rate in sepsis ICU patients

This study tests whether ivabradine (a heart-rate medicine) can improve blood flow and other vital measurements in adults with sepsis in the ICU. It may help by lowering a fast heart rate when blood pressure is already being supported.

Guangzhou, Guangdong

Hear when a new Healthy Adult trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.